{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:33:51Z","timestamp":1788021231946,"version":"build-2784847793"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:00:00Z","timestamp":1607126400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular diseases are the first cause of death worldwide. Among different heart malfunctions, heart valve failure due to calcification is still a challenging problem. While drug-dependent treatment for the early stage calcification could slow down its progression, heart valve replacement is inevitable in the late stages. Currently, heart valve replacements involve mainly two types of substitutes: mechanical and biological heart valves. Despite their significant advantages in restoring the cardiac function, both types of valves suffered from serious drawbacks in the long term. On the one hand, the mechanical one showed non-physiological hemodynamics and the need for the chronic anticoagulation therapy. On the other hand, the biological one showed stenosis and\/or regurgitation due to calcification. Nowadays, new promising heart valve substitutes have emerged, known as decellularized tissue-engineered heart valves (dTEHV). Decellularized tissues of different types have been widely tested in bioprosthetic and tissue-engineered valves because of their superior biomechanics, biocompatibility, and biomimetic material composition. Such advantages allow successful cell attachment, growth and function leading finally to a living regenerative valvular tissue in vivo. Yet, there are no comprehensive studies that are covering the performance of dTEHV scaffolds in terms of their efficiency for the calcification problem. In this review article, we sought to answer the question of whether decellularized heart valves calcify or not. Also, which factors make them calcify and which ones lower and\/or prevent their calcification. In addition, the review discussed the possible mechanisms for dTEHV calcification in comparison to the calcification in the native and bioprosthetic heart valves. For this purpose, we did a retrospective study for all the published work of decellularized heart valves. Only animal and clinical studies were included in this review. Those animal and clinical studies were further subcategorized into 4 categories for each depending on the effect of decellularization on calcification. Due to the complex nature of calcification in heart valves, other in vitro and in silico studies were not included. Finally, we compared the different results and summed up all the solid findings of whether decellularized heart valves calcify or not. Based on our review, the selection of the proper heart valve tissue sources (no immunological provoking residues), decellularization technique (no damaged exposed residues of the decellularized tissues, no remnants of dead cells, no remnants of decellularizing agents) and implantation techniques (avoiding suturing during the surgical implantation) could provide a perfect anticalcification potential even without in vitro cell seeding or additional scaffold treatment.<\/jats:p>","DOI":"10.1007\/s10856-020-06462-x","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T12:02:34Z","timestamp":1607169754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?"],"prefix":"10.1007","volume":"31","author":[{"given":"Adel F.","family":"Badria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros G.","family":"Koutsoukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimosthenis","family":"Mavrilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,5]]},"reference":[{"key":"6462_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-220368","author":"AL Booth","year":"2017","unstructured":"Booth AL, Li CQ, Al-Dossari GA, Stevenson HL. Abundant dystrophic calcifications mimicking aortic valve abscess in a patient undergoing elective aortic valve replacement. BMJ Case Rep. 2017. https:\/\/doi.org\/10.1136\/bcr-2017-220368","journal-title":"BMJ Case Rep"},{"key":"6462_CR2","doi-asserted-by":"publisher","unstructured":"Otto CM, Prendergast, B. Aortic-valve stenosis - From patients at risk to severe valve obstruction. N Engl J Med. 2014. https:\/\/doi.org\/10.1056\/NEJMra1313875","DOI":"10.1056\/NEJMra1313875"},{"key":"6462_CR3","doi-asserted-by":"publisher","unstructured":"Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, et al. Calcific aortic valve disease: Not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group. Circulation. 2011. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.006767","DOI":"10.1161\/CIRCULATIONAHA.110.006767"},{"key":"6462_CR4","doi-asserted-by":"publisher","unstructured":"Steinberg DH. Aortic valve calcification: moving toward the root of the problem. J Am Coll Cardiol. 2019. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.016","DOI":"10.1016\/j.jacc.2018.11.016"},{"key":"6462_CR5","doi-asserted-by":"publisher","unstructured":"Mavrilas D, Apostolakis, E, Koutsoukos P. Prosthetic aortic valves: a surgical and bioengineering approach. In Aortic valve surgery; 2011. https:\/\/doi.org\/10.5772\/20860","DOI":"10.5772\/20860"},{"key":"6462_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3978\/j.issn.2225-319X.2015.07.01","volume":"4","author":"C Harris","year":"2015","unstructured":"Harris C, Croce B, Cao C. Tissue and mechanical heart valves. Ann Cardiothorac Sur. 2015;4:399 https:\/\/doi.org\/10.3978\/j.issn.2225-319X.2015.07.01","journal-title":"Ann Cardiothorac Sur"},{"key":"6462_CR7","doi-asserted-by":"crossref","unstructured":"Filov\u00e1 E, Straka F, Ejovsk\u00fd TMI\u0158, Ma\u0161\u00edn J, \u00c1kov\u00e1 LBA\u010c. Tissue-engineered heart valves; 2009;58:S145\u20136.","DOI":"10.33549\/physiolres.931919"},{"key":"6462_CR8","doi-asserted-by":"publisher","unstructured":"Vesely, I. Heart valve tissue engineering. Circ Res. 2005. https:\/\/doi.org\/10.1161\/01.RES.0000185326.04010.9f","DOI":"10.1161\/01.RES.0000185326.04010.9f"},{"key":"6462_CR9","doi-asserted-by":"publisher","unstructured":"Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Rolf R, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits in vivo restoration of valve tissue. Circulation. 2000;102:Iii-50\u2013Iii-55. https:\/\/doi.org\/10.1161\/01.CIR.102.suppl","DOI":"10.1161\/01.CIR.102.suppl"},{"key":"6462_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/CIRCINTERVENTIONS.112.971028","volume":"5","author":"JA Leopold","year":"2012","unstructured":"Leopold JA. Cellular mechanisms of aortic valve calcification. Circ Cardiovas Interv. 2012;5:605\u201314. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.112.971028","journal-title":"Circ Cardiovas Interv"},{"key":"6462_CR11","doi-asserted-by":"publisher","unstructured":"Hortells L, Sur S, St. Hilaire C. Cell phenotype transitions in cardiovascular calcification. Fron Cardiovas Med. 2018. https:\/\/doi.org\/10.3389\/fcvm.2018.00027","DOI":"10.3389\/fcvm.2018.00027"},{"key":"6462_CR12","doi-asserted-by":"publisher","unstructured":"Sponder M, Fritzer-Szekeres M, Litschauer B, Binder T, Strametz-Juranek J. Endostatin and osteopontin are elevated in patients with both coronary artery disease and aortic valve calcification. IJC Metab Endocr. 2015. https:\/\/doi.org\/10.1016\/j.ijcme.2015.08.002","DOI":"10.1016\/j.ijcme.2015.08.002"},{"key":"6462_CR13","doi-asserted-by":"publisher","unstructured":"Syv\u00e4ranta S, Helske S, Laine M, Lappalainen J, Kupari M, M\u00e4yr\u00e4np\u00e4\u00e4 MI, et al. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis. Arterioscler Thromb Vascul Biol. 2010. https:\/\/doi.org\/10.1161\/ATVBAHA.109.198267","DOI":"10.1161\/ATVBAHA.109.198267"},{"key":"6462_CR14","doi-asserted-by":"publisher","unstructured":"Golub EE. Role of matrix vesicles in biomineralization. Biochim Biophys Acta. 2009. https:\/\/doi.org\/10.1016\/j.bbagen.2009.09.006","DOI":"10.1016\/j.bbagen.2009.09.006"},{"key":"6462_CR15","doi-asserted-by":"publisher","unstructured":"Chen J, Peacock JR, Branch J, David Merryman W . Biophysical analysis of dystrophic and osteogenic models of valvular calcification. J Biomech Eng. 2014. https:\/\/doi.org\/10.1115\/1.4029115","DOI":"10.1115\/1.4029115"},{"key":"6462_CR16","unstructured":"Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: a multifactorial process. Exp Clini Cardiol. 2002;7:40\u201353."},{"key":"6462_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","volume":"121","author":"KL Chan","year":"2010","unstructured":"Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: Measuring effects of rosuvastatin (Astronomer) trial. Circulation. 2010;121:306\u201314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.900027","journal-title":"Circulation"},{"key":"6462_CR18","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","volume":"352","author":"SJ Cowell","year":"2005","unstructured":"Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl Med. 2005;352:2389\u201397. https:\/\/doi.org\/10.1056\/NEJMoa043876","journal-title":"N Engl Med"},{"key":"6462_CR19","doi-asserted-by":"publisher","unstructured":"David TE, Ivanov, J. Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J Thor Cardiovas Surg. 2003. https:\/\/doi.org\/10.1016\/S0022","DOI":"10.1016\/S0022"},{"key":"6462_CR20","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI119265","volume":"99","author":"SS Srivatsa","year":"1997","unstructured":"Srivatsa SS, Harrity PJ, Maercklein PB, Kleppe L, Veinot J, Edwards WD, et al. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Investig. 1997;99:996\u20131009. https:\/\/doi.org\/10.1172\/JCI119265","journal-title":"J Clin Investig"},{"key":"6462_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.athoracsur.2004.06.033","volume":"79","author":"FJ Schoen","year":"2005","unstructured":"Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. The Annp Thor Surg. 2005;79:1072\u201380. https:\/\/doi.org\/10.1016\/j.athoracsur.2004.06.033","journal-title":"The Annp Thor Surg"},{"key":"6462_CR22","doi-asserted-by":"publisher","unstructured":"Glimcher MJ. Mechanism of calcification: role of collagen fibrils and collagen\u2010phosphoprotein complexes in vitro and in vivo. Anat Record. 1989. https:\/\/doi.org\/10.1002\/ar.1092240205","DOI":"10.1002\/ar.1092240205"},{"key":"6462_CR23","doi-asserted-by":"publisher","unstructured":"Veis A, Schlueter RJ. The macromolecular organization of dentine matrix collagen. I. Characterization of Dentine Collagen. Biochemistry. 1964. https:\/\/doi.org\/10.1021\/bi00899a009","DOI":"10.1021\/bi00899a009"},{"key":"6462_CR24","doi-asserted-by":"publisher","unstructured":"Simionescu DT. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Exp Opin Biol Ther. 2004. https:\/\/doi.org\/10.1517\/14712598.4.12.1971","DOI":"10.1517\/14712598.4.12.1971"},{"key":"6462_CR25","doi-asserted-by":"crossref","unstructured":"Demer LL. Lipid hypothesis of cardiovascular calcification. Circulation. 1994;95:297\u20138.","DOI":"10.1161\/01.CIR.95.2.297"},{"key":"6462_CR26","doi-asserted-by":"publisher","unstructured":"Srinivasan M, Sedmak D, Jewell S (2002). Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. https:\/\/doi.org\/10.1016\/S0002-9440(10)64472-0","DOI":"10.1016\/S0002-9440(10)64472-0"},{"key":"6462_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0002-9440(10)65331-X","volume":"154","author":"KM Kim","year":"1999","unstructured":"Kim KM, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol. 1999;154:843\u201352. https:\/\/doi.org\/10.1016\/S0002-9440(10)65331-X","journal-title":"Am J Pathol"},{"key":"6462_CR28","doi-asserted-by":"publisher","unstructured":"Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation. 2005. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.486738","DOI":"10.1161\/CIRCULATIONAHA.104.486738"},{"key":"6462_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejcts.2003.12.013","volume":"25","author":"M Ruel","year":"2004","unstructured":"Ruel M, Kulik A, Rubens FD, B\u00e9dard P, Masters RG, Pipe AL, et al. Late incidence and determinants of reoperation in patients with prosthetic heart valves. Eur J Cardio-thorac Surg. 2004;25:364\u201370. https:\/\/doi.org\/10.1016\/j.ejcts.2003.12.013","journal-title":"Eur J Cardio-thorac Surg"},{"key":"6462_CR30","doi-asserted-by":"publisher","unstructured":"Van Geemen D, Soares ALF, Oomen PJA, Driessen-Mol A, Janssen-Van Den Broek MWJT, Van Den Bogaerdt AJ, et al. Age-dependent changes in geometry, tissue composition and mechanical properties of fetal to adult cryopreserved human heart valves. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0149020","DOI":"10.1371\/journal.pone.0149020"},{"key":"6462_CR31","doi-asserted-by":"publisher","unstructured":"Benton JA, Kern HB, Leinwand LA, Mariner PD, Anseth KS. Statins block calcific nodule formation of valvular interstitial cells by inhibiting \u03b1-smooth muscle actin expression. Arterioscler Thromb Vasc Biol. 2009. https:\/\/doi.org\/10.1161\/ATVBAHA.109.195271","DOI":"10.1161\/ATVBAHA.109.195271"},{"key":"6462_CR32","doi-asserted-by":"publisher","unstructured":"Tomazic BB, Edwards WD, Schoen FJ. Physicochemical characterization of natural and bioprosthetic heart valve calcific deposits: Implications for prevention. Ann Thorac Surg. 1995;60 Suppl. 2. https:\/\/doi.org\/10.1016\/0003-4975(95)00205-Y","DOI":"10.1016\/0003-4975(95)00205-Y"},{"key":"6462_CR33","doi-asserted-by":"publisher","unstructured":"Cottignoli V, Cavarretta E, Salvador L, Valfr\u00e9 C, Maras A. morphological and chemical study of pathological deposits in human aortic and mitral valve stenosis: a biomineralogical contribution. Pathol Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/342984","DOI":"10.1155\/2015\/342984"},{"key":"6462_CR34","doi-asserted-by":"publisher","unstructured":"Rokidi S, Mavrilas D, Koutsoukos PG. Calcification of biomaterials. In Mineral scales and deposits: scientific and technological approaches. United Kingdom: Elsevier; 2015. https:\/\/doi.org\/10.1016\/B978-0-444-63228-9.00016-4","DOI":"10.1016\/B978-0-444-63228-9.00016-4"},{"key":"6462_CR35","doi-asserted-by":"publisher","unstructured":"Li KYC. Bioprosthetic heart valves: upgrading a 50-year old technology. Front Cardiovasc Med. 2019. https:\/\/doi.org\/10.3389\/fcvm.2019.00047","DOI":"10.3389\/fcvm.2019.00047"},{"key":"6462_CR36","doi-asserted-by":"publisher","unstructured":"Naso F, Gandaglia A. Different approaches to heart valve decellularization: a comprehensive overview of the past 30 years. Xenotransplantation. 2018:1\u201310. https:\/\/doi.org\/10.1111\/xen.12354","DOI":"10.1111\/xen.12354"},{"key":"6462_CR37","doi-asserted-by":"publisher","unstructured":"Boroumand S, Asadpour S, Akbarzadeh A, Faridi-majidi R. Heart valve tissue engineering: an overview of heart valve decellularization processes. Regen. Med. 2018. https:\/\/doi.org\/10.2217\/rme-2017-0061C?","DOI":"10.2217\/rme-2017-0061C?"},{"key":"6462_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2018.00054","volume":"5","author":"CVC Bouten","year":"2018","unstructured":"Bouten CVC, Smits AIPM, Baaijens FPT, Hutcheson JD. Can we grow valves inside the heart? Perspective on material- based in situ heart valve tissue engineering. Front Cardiovas Med. 2018;5:1\u201310. https:\/\/doi.org\/10.3389\/fcvm.2018.00054","journal-title":"Front Cardiovas Med"},{"key":"6462_CR39","doi-asserted-by":"publisher","unstructured":"Copeland KM, Wang B, Shi X, Simionescu DT, Hong Y, Bajona P, et al. Decellularization in Heart Valve Tissue Engineering. In: Sacks M., Liao J. (eds) Advances in Heart Valve Biomechanics. Cham: Springer; 2018. https:\/\/doi.org\/10.1007\/978-3-030-01993-8_12","DOI":"10.1007\/978-3-030-01993-8_12"},{"key":"6462_CR40","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1098\/rstb.2007.2131","volume":"362","author":"D Schmidt","year":"2007","unstructured":"Schmidt D, Stock Ua, Hoerstrup SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philosoph Trans R Soc London. Ser B Biol Sci. 2007;362:1505\u201312. https:\/\/doi.org\/10.1098\/rstb.2007.2131","journal-title":"Philosoph Trans R Soc London. Ser B Biol Sci"},{"key":"6462_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ppedcard.2005.11.010","volume":"21","author":"PM Taylor","year":"2006","unstructured":"Taylor PM, Cass AEG, Yacoub MH. Extracellular matrix scaffolds for tissue engineering heart valves. Prog Pediatric Cardiol. 2006;21:219\u201325. https:\/\/doi.org\/10.1016\/j.ppedcard.2005.11.010","journal-title":"Prog Pediatric Cardiol"},{"key":"6462_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1515\/bmt-2012-0115","volume":"2013","author":"A Neumann","year":"2013","unstructured":"Neumann A, Cebotari S, Tudorache I, Haverich A, Sarikouch S. Heart valve engineering: decellularized allograft matrices in clinical practice. Biomed Tech. 2013;2013:6\u20139. https:\/\/doi.org\/10.1515\/bmt-2012-0115","journal-title":"Biomed Tech"},{"key":"6462_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1243\/09544119JEIM230","volume":"222","author":"RL Knight","year":"2008","unstructured":"Knight RL, Wilcox HE, Korossis SA, Fisher J, Ingham E. The use of acellular matrices for the tissue engineering of cardiac valves. J. Eng Med. 2008;222:129\u201343. https:\/\/doi.org\/10.1243\/09544119JEIM230","journal-title":"J. Eng Med"},{"key":"6462_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2005.05.100","volume":"27","author":"Ua, Stock","year":"2006","unstructured":"Stock Ua, Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials. 2006;27:1\u20132. https:\/\/doi.org\/10.1016\/j.biomaterials.2005.05.100","journal-title":"Biomaterials"},{"key":"6462_CR45","doi-asserted-by":"publisher","unstructured":"Smit FE, Botes L, van den Heever JJ, Laker L, Dohmen PM. Decellularized sterile-stabilized bovine pericardial (DSBP) scaffolds: recellularization, comparative strength and calcification compared to glutaraldehyde crosslinked pericardial patches in the Juvenile Ovine Model. Structural Heart. 2019. https:\/\/doi.org\/10.1080\/24748706.2019.1589332","DOI":"10.1080\/24748706.2019.1589332"},{"key":"6462_CR46","doi-asserted-by":"publisher","unstructured":"Bruder L, Spriestersbach H, Brakmann K, Stegner V, Sigler M, Berger F, et al. Transcatheter decellularized tissue-engineered heart valve (dTEHV) grown on polyglycolic acid (PGA) scaffold coated with P4HB shows improved functionality over 52 weeks due to polyether-ether-ketone (PEEK) insert. J Funct Biomater. 2018. https:\/\/doi.org\/10.3390\/jfb9040064","DOI":"10.3390\/jfb9040064"},{"key":"6462_CR47","unstructured":"Vesely I, Noseworthy R. Culture of human aortic fibroblasts on porcine bioprosthetic valves. Can J Cardiol. 1992;8(Suppl B):65B."},{"key":"6462_CR48","unstructured":"O\u2019Brien M. Frf Goldstein S, Walso S, Black KS, Elkins R, Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999. S1043067999000787 [pii]."},{"key":"6462_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/10731199.2011.637925","volume":"40","author":"P Somers","year":"2012","unstructured":"Somers P, de Somer F, Cornelissen M, Thierens H, Van Nooten G. Decellularization of heart valve matrices: search for the ideal balance. Artif Cells Blood Substit Biotechnol. 2012;40:151\u201362. https:\/\/doi.org\/10.3109\/10731199.2011.637925","journal-title":"Artif Cells Blood Substit Biotechnol"},{"key":"6462_CR50","doi-asserted-by":"publisher","unstructured":"van Steenberghe M, Schubert T, Gerelli S, Bouzin C, Guiot Y, Xhema D, et al. Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments. J Cardiothorac Surg. 2018. https:\/\/doi.org\/10.1186\/s13019-018-0720-y","DOI":"10.1186\/s13019-018-0720-y"},{"key":"6462_CR51","doi-asserted-by":"publisher","unstructured":"Meyer SR, Chiu B, Churchill TA, Zhu L, Lakey JRT, Ross DB. Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res. 2006:254\u201362. https:\/\/doi.org\/10.1002\/jbm.a","DOI":"10.1002\/jbm.a"},{"key":"6462_CR52","doi-asserted-by":"crossref","unstructured":"Dettin M, Zamuner A, Naso F, Monteleone A, Spina M, Gerosa G. Natural scaffolds for regenerative medicine: decellularized heart valves. BioMed Res Int. 2017.","DOI":"10.1155\/2017\/9274135"},{"key":"6462_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/icvts\/ivx316","volume":"26","author":"J Haupt","year":"2018","unstructured":"Haupt J, Lutter G, Gorb SN, Simionescu DT, Frank D, Seiler J, et al. Detergent-based decellularization strategy preserves macro- and microstructure of heart valves. Interact Cardiovasc Thorac Surg. 2018;26:230\u20136. https:\/\/doi.org\/10.1093\/icvts\/ivx316","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"6462_CR54","doi-asserted-by":"publisher","unstructured":"Flameng, W, De Visscher, G, Mesure, L, Hermans, H, Jashari, R, & Meuris, B. Coating with fibronectin and stromal cell-derived factor-1\u03b1 of decellularized homografts used for right ventricular outflow tract reconstruction eliminates immune response-related degeneration. J Thorac Cardiovas Surg. 2014; 147. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.06.022","DOI":"10.1016\/j.jtcvs.2013.06.022"},{"key":"6462_CR55","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1016\/j.biomaterials.2009.07.068","volume":"30","author":"H Baraki","year":"2009","unstructured":"Baraki H, Tudorache I, Braun M, H\u00f6ffler K, G\u00f6rler A, Lichtenberg A, et al. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials. 2009;30:6240\u20136. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.07.068","journal-title":"Biomaterials"},{"key":"6462_CR56","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/S0022-5223(03)00956-5","volume":"126","author":"R Grauss","year":"2003","unstructured":"Grauss R, Hazekamp M, van Vliet S, Gittenberger-de Groot a, DeRuiter M. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J Thorac Cardiovas Surg. 2003;126:2003\u201310. https:\/\/doi.org\/10.1016\/S0022-5223(03)00956-5","journal-title":"J Thorac Cardiovas Surg"},{"key":"6462_CR57","first-page":"BR97","volume":"9","author":"PM Dohmen","year":"2003","unstructured":"Dohmen PM, Ozaki S, Nitsch R, Yperman J, Flameng W, Konertz W. A tissue engineered heart valve implanted in a juvenile sheep model. Med Sci Monit. 2003;9:BR97\u2013BR104. 3299 [pii].","journal-title":"Med Sci Monit"},{"key":"6462_CR58","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ejcts.2004.12.057","volume":"27","author":"FDA da Costa","year":"2005","unstructured":"da Costa FDA, Dohmen PM, Duarte D, von Glenn C, Lopes SV, Filho HH, et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur J Cardio-Thorac Surg. 2005;27:572\u20138. https:\/\/doi.org\/10.1016\/j.ejcts.2004.12.057","journal-title":"Eur J Cardio-Thorac Surg"},{"key":"6462_CR59","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1089\/ten.2006.12.2059","volume":"12","author":"W Erdbr\u00fcgger","year":"2006","unstructured":"Erdbr\u00fcgger W, Konertz W, Dohmen PM, Posner S, Ellerbrok H, Brodde O-E, et al. Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. Tissue Eng. 2006;12:2059\u201368. https:\/\/doi.org\/10.1089\/ten.2006.12.2059","journal-title":"Tissue Eng"},{"key":"6462_CR60","doi-asserted-by":"publisher","unstructured":"Iop L, Bonetti A, Naso F, Rizzo S, Cagnin S, Bianco R, et al. Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation. PLoS ONE. 2014;9. https:\/\/doi.org\/10.1371\/journal.pone.0099593","DOI":"10.1371\/journal.pone.0099593"},{"key":"6462_CR61","unstructured":"Acharya G, Armstrong M, McFall C, Quinn RW, Hilbert SL, Converse, GL, et al. Calcium and phosphorus concentrations in native and decellularized semilunar valve tissues. J Heart Valve Dis. 2014;23:259\u201370."},{"key":"6462_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.athoracsur.2011.03.039","volume":"92","author":"RW Quinn","year":"2011","unstructured":"Quinn RW, Hilbert SL, Bert AA, Drake BW, Bustamante JA, Fenton JE, et al. Performance and morphology of decellularized pulmonary valves implanted in juvenile sheep. Ann Thorac Surg. 2011;92:131\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.03.039","journal-title":"Ann Thorac Surg"},{"key":"6462_CR63","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.athoracsur.2006.11.083","volume":"83","author":"T Ota","year":"2007","unstructured":"Ota T, Taketani S, Iwai S, Miyagawa S, Furuta M, Hara M, et al. Novel method of decellularization of porcine valves using polyethylene glycol and gamma irradiation. Ann Thorac Surg. 2007;83:1501\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2006.11.083","journal-title":"Ann Thorac Surg"},{"key":"6462_CR64","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1016\/j.biomaterials.2006.03.047","volume":"27","author":"A Lichtenberg","year":"2006","unstructured":"Lichtenberg A, Tudorache I, Cebotari S, Ringes-Lichtenberg S, Sturz G, Hoeffler K, et al. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials. 2006;27:4221\u20139. https:\/\/doi.org\/10.1016\/j.biomaterials.2006.03.047","journal-title":"Biomaterials"},{"key":"6462_CR65","doi-asserted-by":"crossref","unstructured":"Teebken O, Mertsching H, Haverich A. Modification of heart valve allografts and xenografts by means of tissue engineering. Transplant Proc. 2002;34:2333 http:\/\/scholar.google.com\/scholar?hl=en&btnG=Search&q=intitle:Modification+of+heart+valve+allografts+and+xenografts+by+means+of+Tissue+Engineering#0","DOI":"10.1016\/S0041-1345(02)03256-6"},{"key":"6462_CR66","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.biomaterials.2009.11.088","volume":"31","author":"J Zhou","year":"2010","unstructured":"Zhou J, Fritze O, Schleicher M, Wendel H-P, Schenke-Layland K, Harasztosi C, et al. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity. Biomaterials. 2010;31:2549\u201354. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.11.088","journal-title":"Biomaterials"},{"key":"6462_CR67","first-page":"823","volume":"15","author":"PM Dohmen","year":"2006","unstructured":"Dohmen PM, da Costa F, Yoshi S, Lopes SV, da Souza FP, Vilani R, et al. Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding? J Heart Valve Dis. 2006;15:823\u20139.","journal-title":"J Heart Valve Dis"},{"key":"6462_CR68","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jtcvs.2008.12.009","volume":"137","author":"RA Hopkins","year":"2009","unstructured":"Hopkins RA, Jones AL, Wolfinbarger L, Moore MA, Bert AA, Lofland GK. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. J Thorac Cardiovas Surg. 2009;137:907\u201313. https:\/\/doi.org\/10.1016\/j.jtcvs.2008.12.009. 913e1-4.","journal-title":"J Thorac Cardiovas Surg"},{"key":"6462_CR69","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1089\/ten.TEA.2012.0074","volume":"19","author":"I Tudorache","year":"2013","unstructured":"Tudorache I, Calistru A, Baraki H, Meyer T, H\u00f6ffler K, Sarikouch S, et al. Orthotopic replacement of aortic heart valves with tissue-engineered grafts. Tissue Eng A. 2013;19:1686\u201394. https:\/\/doi.org\/10.1089\/ten.TEA.2012.0074","journal-title":"Tissue Eng A"},{"key":"6462_CR70","doi-asserted-by":"publisher","unstructured":"Schmitt, B, Spriestersbach, H, O H-Ic\u00ed, D, Radtke, T, Bartosch, M, Peters, H, et al. Percutaneous pulmonary valve replacement using completely tissue-engineered off-the-shelf heart valves: Six-month in vivo functionality and matrix remodelling in sheep. EuroIntervention. 2016. https:\/\/doi.org\/10.4244\/EIJV12I1A12","DOI":"10.4244\/EIJV12I1A12"},{"key":"6462_CR71","doi-asserted-by":"publisher","unstructured":"Sturla F, Ronzoni M, Vitali M, Dimasi A, Vismara R, Preston-Maher G, et al. Impact of different aortic valve calcification patterns on the outcome of transcatheter aortic valve implantation: a finite element study. J Biomech. 2016. https:\/\/doi.org\/10.1016\/j.jbiomech.2016.03.036","DOI":"10.1016\/j.jbiomech.2016.03.036"},{"key":"6462_CR72","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.thromres.2004.07.020","volume":"114","author":"RK Andrews","year":"2004","unstructured":"Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114:447\u201353. https:\/\/doi.org\/10.1016\/j.thromres.2004.07.020","journal-title":"Thromb Res"},{"key":"6462_CR73","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0003-4975(02)04845-2","volume":"75","author":"RG Leyh","year":"2003","unstructured":"Leyh RG, Wilhelmi M, Rebe P, Fischer S, Kofidis T, Haverich A, et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann Thorac Surg. 2003;75:1457\u201363. https:\/\/doi.org\/10.1016\/S0003-4975(02)04845-2","journal-title":"Ann Thorac Surg"},{"key":"6462_CR74","doi-asserted-by":"publisher","first-page":"I559","DOI":"10.1161\/CIRCULATIONAHA.105.001206","volume":"114","author":"A Lichtenberg","year":"2006","unstructured":"Lichtenberg A, Tudorache I, Cebotari S, Suprunov M, Tudorache G, Goerler H, et al. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation. 2006;114:I559\u201365. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.001206","journal-title":"Circulation"},{"key":"6462_CR75","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1510\/icvts.2006.136267","volume":"5","author":"G Van Nooten","year":"2006","unstructured":"Van Nooten G, Somers P, Cornelissen M, Bouchez S, Gasthuys F, Cox E, et al. Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV valves in the sheep model. Interact Cardiovasc Thorac Surg. 2006;5:544\u20139. https:\/\/doi.org\/10.1510\/icvts.2006.136267","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"6462_CR76","doi-asserted-by":"publisher","unstructured":"VeDepo M, Buse E, Paul A, Hopkins R, Converse, G. Comparison of candidate cell populations for the recellularization of decellularized heart valves. Cell Mol Bioeng. 2018. https:\/\/doi.org\/10.1007\/s12195-018-0524-0","DOI":"10.1007\/s12195-018-0524-0"},{"key":"6462_CR77","doi-asserted-by":"publisher","unstructured":"Valves HH, Jiao T, Ph D, Clifton RJ, Converse GL, Hopkins, RA. Measurements of the effects of decellularization on viscoelastic properties of tissues. 2012;18. https:\/\/doi.org\/10.1089\/ten.tea.2010.0677","DOI":"10.1089\/ten.tea.2010.0677"},{"key":"6462_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2041731417726327","volume":"8","author":"MC VeDepo","year":"2017","unstructured":"VeDepo MC, Detamore MS, Hopkins RA, Converse GL. Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve. J Tissue Eng. 2017;8:1\u201321. https:\/\/doi.org\/10.1177\/2041731417726327","journal-title":"J Tissue Eng"},{"key":"6462_CR79","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S0003-4975(02)03881-X","volume":"74","author":"PM Dohmen","year":"2002","unstructured":"Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg. 2002;74:1438\u201342. https:\/\/doi.org\/10.1016\/S0003-4975(02)03881-X","journal-title":"Ann Thorac Surg"},{"key":"6462_CR80","unstructured":"Cheung DY, Wu S, Duan B, Butcher JT. Bioprinting of living aortic valve. In Khademhosseini A, G Camci-Unal, G, editors. 3D bioprinting in regenerative engineering. Boca Raton: Taylor & Francis; 2018"},{"key":"6462_CR81","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1010-7940(03)00094-0","volume":"23","author":"P Simon","year":"2003","unstructured":"Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U. et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J CardioThorc Surg. 2003;23:1002\u20136. https:\/\/doi.org\/10.1016\/S1010-7940(03)00094-0.","journal-title":"Eur J CardioThorc Surg"},{"key":"6462_CR82","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jtcvs.2009.04.065","volume":"139","author":"JW Brown","year":"2010","unstructured":"Brown JW, Elkins RC, Clarke DR, Tweddell JS, Huddleston CB, Doty JR, et al. Performance of the CryoValve SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years. J Thorac Cardiovasc Surg. 2010;139:339\u201348. https:\/\/doi.org\/10.1016\/j.jtcvs.2009.04.065","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6462_CR83","doi-asserted-by":"publisher","unstructured":"Boethig D, Horke A, Hazekamp M, Meyns B, Rega F, Van Puyvelde J, et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data. Eur J CardioThorc Surg. 2019. https:\/\/doi.org\/10.1093\/ejcts\/ezz054","DOI":"10.1093\/ejcts\/ezz054"},{"key":"6462_CR84","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/stcs.2001.22989","volume":"13","author":"RC Elkins","year":"2001","unstructured":"Elkins RC, Goldstein S, Hewitt CW, Walsh SP, Dawson PE, Ollerenshaw JD, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg. 2001;13:87\u201392.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"6462_CR85","unstructured":"Dohmen PM, Ozaki S, Nitsch R, Yperman J, Flameng W, Konertz W. A tissue engineered heart valve implanted in a juvenile sheep model. Med Sci Monit. 2003;9:BR97\u2013104."},{"key":"6462_CR86","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1590\/S0102-76382010000300015","volume":"25","author":"FB Navarro","year":"2010","unstructured":"Navarro FB, Costa FDA, Da, Mulinari LA, Pimentel GK, Roderjan JG, et al. Evaluation of the biological behavior of decellularized pulmonary homografts: an experimental sheep model. Rev Bras Cir Cardiovasc. 2010;25:377\u201387. https:\/\/doi.org\/10.1590\/S0102-76382010000300015","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"6462_CR87","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ejcts.2010.08.054","volume":"39","author":"JL Honge","year":"2011","unstructured":"Honge JL, Funder J, Hansen E, Dohmen PM, Konertz W, Hasenkam JM. Recellularization of aortic valves in pigs. Eur J Cardiothorac Surgery. 2011;39:829\u201334. https:\/\/doi.org\/10.1016\/j.ejcts.2010.08.054","journal-title":"Eur J Cardiothorac Surgery"},{"key":"6462_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.02.023","author":"K Theodoridis","year":"2015","unstructured":"Theodoridis K, Tudorache I, Calistru A, Cebotari S, Meyer T, Sarikouch S, et al. Successful matrix guided tissue regeneration of decellularized pulmonary heart valve allografts in elderly sheep. Biomaterials. 2015. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.02.023","journal-title":"Biomaterials"},{"key":"6462_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-018-0720-y","author":"M van Steenberghe","year":"2018","unstructured":"van Steenberghe M, Schubert T, Gerelli S, Bouzin C, Guiot Y, Xhema D, et al. Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments. J Cardiothorac Surg. 2018. https:\/\/doi.org\/10.1186\/s13019-018-0720-y","journal-title":"J Cardiothorac Surg"},{"key":"6462_CR90","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0022-5223(03)00353-2","volume":"126","author":"R Leyh","year":"2003","unstructured":"Leyh R, Wilhelmi M, Walles T, Kallenbach K, Rebe P, Oberbeck a, et al. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. J Cardiothorac Surg. 2003;126:1000\u20134. https:\/\/doi.org\/10.1016\/S0022-5223(03)00353-2","journal-title":"J Cardiothorac Surg"},{"key":"6462_CR91","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jtcvs.2005.03.021","volume":"130","author":"SR Meyer","year":"2005","unstructured":"Meyer SR, Nagendran J, Desai LS, Rayat GR, Churchill Ta, Anderson CC, et al. Decellularization reduces the immune response to aortic valve allografts in the rat. J Cardiothorac Surg. 2005;130:469\u201376. https:\/\/doi.org\/10.1016\/j.jtcvs.2005.03.021","journal-title":"J Cardiothorac Surg"},{"key":"6462_CR92","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jbm.a.30777","volume":"79","author":"SR Meyer","year":"2006","unstructured":"Meyer SR, Chiu B, Churchill TA, Zhu L, Lakey JRT, Ross DB. Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res A. 2006;79:254\u201362. https:\/\/doi.org\/10.1002\/jbm.a.30777","journal-title":"J Biomed Mater Res A"},{"key":"6462_CR93","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1016\/j.biomaterials.2013.04.059","volume":"34","author":"B Weber","year":"2013","unstructured":"Weber B, Dijkman PE, Scherman J, Sanders B, Emmert MY, Gr\u00fcnenfelder J, et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials. 2013;34:7269\u201380. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.04.059","journal-title":"Biomaterials"},{"key":"6462_CR94","doi-asserted-by":"publisher","unstructured":"Haverich A, Hilfiker A. Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies. 2016:1\u201313. https:\/\/doi.org\/10.1007\/s00395-016-0560-7","DOI":"10.1007\/s00395-016-0560-7"},{"key":"6462_CR95","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jtcvs.2005.03.044","volume":"130","author":"KJ Zehr","year":"2005","unstructured":"Zehr KJ, Yagubyan M, Connolly HM, Nelson SM, Schaff HV. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results. J Cardiothorac Surg. 2005;130:1010\u20135. https:\/\/doi.org\/10.1016\/j.jtcvs.2005.03.044","journal-title":"J Cardiothorac Surg"},{"key":"6462_CR96","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.athoracsur.2007.04.072","volume":"84","author":"PM Dohmen","year":"2007","unstructured":"Dohmen PM, Lembcke A, Holinski S, Kivelitz D, Braun JP, Pruss A, et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg. 2007;84:729\u201336. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.04.072","journal-title":"Ann Thorac Surg"},{"key":"6462_CR97","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/S0102-76382008000200008","volume":"23","author":"LA Mulinari","year":"2008","unstructured":"Mulinari LA, Navarro FB, Pimentel GK, Miyazaki SM, Binotto CN, Pelissari EC, et al. The use and midium-term evaluation of decellularized allograft cusp in the surgical treatment of the tetralogy of fallot. Rev Bras Cir Cardiovasc. 2008;23:197\u2013203. https:\/\/doi.org\/10.1590\/S0102-76382008000200008","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"6462_CR98","unstructured":"da Costa FDA, Santos LR, Collatusso C, Matsuda CN, Lopes SaV, Cauduro S, et al. Thirteen years\u2019 experience with the Ross Operation. J Heart Valve Dis. 2009;18:84\u201394. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19301558"},{"key":"6462_CR99","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.athoracsur.2010.08.022","volume":"90","author":"FDA da Costa","year":"2010","unstructured":"da Costa FDA, Costa ACBA, Prestes R, Domanski AC, Balbi EM, Ferreira ADA, et al. The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg. 2010;90:1854\u201360. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.08.022","journal-title":"Ann Thorac Surg"},{"key":"6462_CR100","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejcts.2010.01.044","volume":"38","author":"A R\u00fcffer","year":"2010","unstructured":"R\u00fcffer A, Purbojo A, Cicha I, Gl\u00f6ckler M, Potapov S, Dittrich S, et al. Early failure of xenogenous de-cellularised pulmonary valve conduits-a word of caution! Eur J Cardiothorac Surg. 2010;38:78\u201385. https:\/\/doi.org\/10.1016\/j.ejcts.2010.01.044","journal-title":"Eur J Cardiothorac Surg"},{"key":"6462_CR101","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.athoracsur.2011.06.009","volume":"92","author":"PM Dohmen","year":"2011","unstructured":"Dohmen PM, Lembcke A, Holinski S, Pruss A, Konertz W. Ten years of clinical results with a tissue-engineered pulmonary valve. Ann Thorac Surg. 2011;92:1308\u201314. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.06.009","journal-title":"Ann Thorac Surg"},{"key":"6462_CR102","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1161\/CIRCULATIONAHA.110.012161","volume":"124","author":"S Cebotari","year":"2011","unstructured":"Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation. 2011;124:S115\u201323. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.012161","journal-title":"Circulation"},{"key":"6462_CR103","doi-asserted-by":"publisher","unstructured":"Bobylev, D, Sarikouch, S, Tudorache, I, Cvitkovic, T, S\u00f6ylen, B, Boethig, D, et al. Double semilunar valve replacement in complex congenital heart disease using decellularized homografts. Interact Cardiovasc Thorac Surg. 2019. https:\/\/doi.org\/10.1093\/icvts\/ivy212","DOI":"10.1093\/icvts\/ivy212"},{"key":"6462_CR104","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jtcvs.2006.02.038","volume":"132","author":"DV Miller","year":"2006","unstructured":"Miller DV, Edwards WD, Zehr KJ. Endothelial and smooth muscle cell populations in a decellularized cryopreserved aortic homograft (SynerGraft) 2 years after implantation. J Thorac Cardiovasc Surg. 2006;132:175\u20136. https:\/\/doi.org\/10.1016\/j.jtcvs.2006.02.038","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6462_CR105","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1089\/ten.tea.2011.0046","volume":"17","author":"O Bloch","year":"2011","unstructured":"Bloch O, Sc M, Golde P, Dohmen PM, Ph D, Posner S, et al. Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves. Tissue Eng. 2011;17:2399\u2013405. https:\/\/doi.org\/10.1089\/ten.tea.2011.0046","journal-title":"Tissue Eng"},{"key":"6462_CR106","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.athoracsur.2009.06.003","volume":"88","author":"T Konuma","year":"2009","unstructured":"Konuma T, Devaney EJ, Bove EL, Gelehrter S, Hirsch JC, Tavakkol Z, et al. Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2009;88:849\u201354. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.06.003. Discussion 554-5.","journal-title":"Ann Thorac Surg"},{"key":"6462_CR107","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.athoracsur.2010.05.024","volume":"90","author":"PT Burch","year":"2010","unstructured":"Burch PT, Kaza AK, Lambert LM, Holubkov R, Shaddy RE, Hawkins JA. Clinical performance of decellularized cryopreserved valved allografts compared with standard allografts in the right ventricular outflow tract. Ann Thorac Surg. 2010;90:1301\u20135. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.05.024","journal-title":"Ann Thorac Surg"},{"key":"6462_CR108","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.athoracsur.2005.04.017","volume":"80","author":"Z Tavakkol","year":"2005","unstructured":"Tavakkol Z, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Superior durability of SynerGraft pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2005;80:1610\u20134. https:\/\/doi.org\/10.1016\/j.athoracsur.2005.04.017","journal-title":"Ann Thorac Surg"},{"key":"6462_CR109","doi-asserted-by":"publisher","first-page":"I132","DOI":"10.1161\/CIRCULATIONAHA.105.001065","volume":"114","author":"S Cebotari","year":"2006","unstructured":"Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation. 2006;114:I132\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.001065","journal-title":"Circulation"},{"key":"6462_CR110","doi-asserted-by":"crossref","unstructured":"Costa F, Dohmen P, Vieira E, Lopes SV, Colatusso C, Pereira EWL, et al. Ross Operation with decellularized pulmonary allografts: medium-term results. Rev Bras Cir Cardiovasc. 2007;22:454\u201362. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18488113","DOI":"10.1590\/S0102-76382007000400012"},{"key":"6462_CR111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.carpath.2010.04.006","volume":"20","author":"I Cicha","year":"2011","unstructured":"Cicha I, R\u00fcffer A, Cesnjevar R, Gl\u00f6ckler M, Agaimy A, Daniel WG, et al. Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes. Cardiovasc Pathol. 2011;20:222\u201331. https:\/\/doi.org\/10.1016\/j.carpath.2010.04.006","journal-title":"Cardiovasc Pathol"},{"key":"6462_CR112","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jtcvs.2011.12.032","volume":"143","author":"M Ruzmetov","year":"2012","unstructured":"Ruzmetov M, Shah JJ, Geiss DM, Fortuna RS. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison. J Thorac Cardiovasc Surg. 2012;143:543\u20139. https:\/\/doi.org\/10.1016\/j.jtcvs.2011.12.032","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6462_CR113","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.athoracsur.2010.10.069","volume":"91","author":"JW Brown","year":"2011","unstructured":"Brown JW, Ruzmetov M, Eltayeb O, Rodefeld MD, Turrentine MW. Performance of SynerGraft decellularized pulmonary homograft in patients undergoing a Ross procedure. Ann Thorac Surg. 2011;91:416\u201322. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.10.069. Discussion 422-3.","journal-title":"Ann Thorac Surg"},{"key":"6462_CR114","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1399-0039.2012.01885.x","volume":"80","author":"C Kneib","year":"2012","unstructured":"Kneib C, von Glehn CQC, Costa FDa, Costa MTBa, Susin MF. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts. Tissue Antigens. 2012;80:165\u201374. https:\/\/doi.org\/10.1111\/j.1399-0039.2012.01885.x","journal-title":"Tissue Antigens"},{"key":"6462_CR115","doi-asserted-by":"publisher","unstructured":"Ozawa H, Ueno T, Taira M, Toda K, Kuratani T, Sawa Y. Application of a fresh decellularized pulmonary allograft for pulmonary valve replacement in Japan. Circ. J. 2018. https:\/\/doi.org\/10.1253\/circj.cj-18-0150","DOI":"10.1253\/circj.cj-18-0150"},{"key":"6462_CR116","doi-asserted-by":"publisher","unstructured":"Christ, T, Paun, AC, Grubitzsch, H, Holinski, S, Falk, V, Dushe, S. Long-term results after the Ross procedure with the decellularized AutoTissue Matrix P\u00ae bioprosthesis used for pulmonary valve replacement. Eur J CardioThorc Surg. 2018. https:\/\/doi.org\/10.1093\/ejcts\/ezy377","DOI":"10.1093\/ejcts\/ezy377"},{"key":"6462_CR117","doi-asserted-by":"publisher","unstructured":"Sarikouch, S, Horke, A, Tudorache, I, Beerbaum, P, Westhoff-Bleck, M, Boethig, D, et al. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J CardioThorc Surg. 2016. https:\/\/doi.org\/10.1093\/ejcts\/ezw050","DOI":"10.1093\/ejcts\/ezw050"},{"key":"6462_CR118","doi-asserted-by":"publisher","unstructured":"Tudorache, I, Horke, A, Cebotari, S, Sarikouch, S, Boethig, D, Breymann, T, et al. Decellularized aortic homografts for aortic valve and aorta ascendens replacement. Eur J Cardiothorc Surg. 2016. https:\/\/doi.org\/10.1093\/ejcts\/ezw013","DOI":"10.1093\/ejcts\/ezw013"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10856-020-06462-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:50:57Z","timestamp":1618599057000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10856-020-06462-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":118,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6462"],"URL":"https:\/\/doi.org\/10.1007\/s10856-020-06462-x","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"132"}}